CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This is a Phase 2 study for BT5528 in adults with a specific type of pancreatic cancer called metastatic pancreatic ductal adenocarcinoma (P...
Phase 2
Philadelphia, Pennsylvania, United States
The research study is being conducted to study whether performing injections of a new treatment, called RP2, directly into stomach and esophagus tumo...
Phase 2
Philadelphia, Pennsylvania, United States
(CLDN18.2)-positive, human epidermal growth factor receptor 2 (HER2)-negative, gastric, gastroesophageal junction (GEJ), and esophageal adenocarcinoma...
Phase 3
Philadelphia, Pennsylvania, United States and 229 other locations
This study will evaluate the safety and effectiveness of the combination of pembrolizumab and odetiglucan in patients with metastatic colorectal canc...
Phase 2
Philadelphia, Pennsylvania, United States
The purpose of this study is to compare overall survival of quemliclustat, nab-paclitaxel and gemcitabine versus placebo, nab-paclitaxel and gemcitab...
Phase 3
Philadelphia, Pennsylvania, United States of America and 124 other locations
resectable gastric, gastroesophageal junction (GEJ), or esophageal adenocarcinoma who have not received previous treatment for the disease....
Phase 2
Newark, Delaware, United States and 69 other locations
The goal of this clinical trial is to determine clinical advantages for LP-300 in combination with carboplatin and pemetrexed in the never smoker pat...
Phase 2
Philadelphia, Pennsylvania, United States of America and 16 other locations
The purpose of this study is to test any good and bad effects of the study drug called PEGPH20. PEGPH20 alone is considered investigational. The Food...
Allentown, Pennsylvania, United States and 9 other locations
The purpose of this study is to combine standard radiation therapy with drugs that encourages the body's immune system against cancer cells and simul...
Phase 2
Philadelphia, Pennsylvania, United States and 4 other locations
The purpose of this study is to evaluate the safety and efficacy of a novel RAS(ON) inhibitor compared to standard(s) of care (SOC) treatment.
Phase 3
Philadelphia, Pennsylvania, United States and 59 other locations
Clinical trials
Research sites
Resources
Legal